41 research outputs found
The clinical significance of urinary tract infection and Asymptomatic Bacteriuria in Type 2 Diabetes Mellitus patients in the general practices of Varna region - Bulgaria
Background: The urinary system of diabetics is one of their most frequently affected body systems. Periodic urine analysis reveals that asymptomatic bacteriuria is very often detected in this population. Objectives: The aim of the study is to estimate the clinical significance of upper urinary tract infection (UUT/) and asymptomatic bacteriuria (ABU) in diabetics in a general practice setting, their clinical characteristics, incidence, course, evolution and complications. Methods: We tested 560 patients with type 2 diabetes mellitus (DM) from 12 general practices ofVarna region, Bulgaria in a prospective study. We traced ABU in the group for 2 years. There were 310 female patients (55.4%) mean age 52.5 ± 3.2 years and duration of DM was 8.5 ± 2.8 years. Results: The results showed that in 11.14% ABU was significant. Only 4.82% of diabetics developed upper urinary tract infection and the complications from it were very rare: 0.89% pyonephrosis and 0.89% sepsis. Conclusions: Our conclusion was that upper urinary tract infection in diabetics was not as severe as reported in the literature. Pyelonephritis had a benign course and only 16.6% of our patients developed chronic renal failure a few years later but the reason for its development was not diabetic nephropathy. All these facts show that ABU disappears spontaneously in most diabetics. Relevance to general practice: We discuss the question: is it necessary for every case of ABU in diabetics in general practice to be treated and isn't it time to revaluate the postulated antibiotic treatment for diabetics with ABU?peer-reviewe
Energy system decarbonization and productivity gains reduced the coupling of CO2 emissions and economic growth in 73 countries between 1970 and 2016
Industrial Ecolog
What research agenda could be generated from the European General Practice Research Network concept of Multimorbidity in Family Practice?
This is the final version of the article. Available from the publisher via the DOI in this record.BACKGROUND: Multimorbidity is an intuitively appealing, yet challenging, concept for Family Medicine (FM). An EGPRN working group has published a comprehensive definition of the concept based on a systematic review of the literature which is closely linked to patient complexity and to the biopsychosocial model. This concept was identified by European Family Physicians (FPs) throughout Europe using 13 qualitative surveys. To further our understanding of the issues around multimorbidity, we needed to do innovative research to clarify this concept. The research question for this survey was: what research agenda could be generated for Family Medicine from the EGPRN concept of Multimorbidity? METHODS: Nominal group design with a purposive panel of experts in the field of multimorbidity. The nominal group worked through four phases: ideas generation phase, ideas recording phase, evaluation and analysis phase and a prioritization phase. RESULTS: Fifteen international experts participated. A research agenda was established, featuring 6 topics and 11 themes with their corresponding study designs. The highest priorities were given to the following topics: measuring multimorbidity and the impact of multimorbidity. In addition the experts stressed that the concept should be simplified. This would be best achieved by working in reverse: starting with the outcomes and working back to find the useful variables within the concept. CONCLUSION: The highest priority for future research on multimorbidity should be given to measuring multimorbidity and to simplifying the EGPRN model, using a pragmatic approach to determine the useful variables within the concept from its outcomes.The study had a Grant of 8000 Euros from the EGPRN
External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort)
Background: Due to the heterogeneous and systemic nature of the chronic obstructive pulmonary disease (COPD), the new guidelines are oriented toward individualized attention. Multidimensional scales could facilitate its proper clinical and prognostic assessment, but not all of them were validated in an international primary care cohort, different from the original ones used for model development. Therefore, our main aim is to assess the prognostic capacity of the ADO, BODEx and DOSE indices in primary care for predicting mortality in COPD patients and to validate the models obtained in subgroups of patients, classified by revised Global Initiative for Chronic Obstructive Lung Disease (2011) and updated Spanish Guideline (2014). Besides, we want to confirm that the prognostic capacity of all indices increases if the number of exacerbations is substituted by the interval between them and to assess the impact on health of the patient''s lifestyle, social network and adherence to treatment. Methods: Design: External validation of scales, open and prospective cohort study in primary care. Setting: 36 health centres in 6 European high, medium and low income countries. Subjects: 477 patients diagnosed with COPD, captured in clinical visit by their General Practitioner/Nurse. Predictors: Detailed patient history, exacerbations, lung function test and questionnaires at baseline. Outcomes: Exacerbations, all-cause mortality and specific mortality, within 5 years of recruitment. Analysis: Multivariate logistic regression and Cox regression will be used. Possible non-linear effect of the indices will be studied by using Structured Additive Regression models with penalised splines. Subsequently, we will assess different aspects of the regression models: discrimination, calibration and diagnostic precision. Clinical variables modulated in primary care and the interval between exacerbations will be considered and incorporated into the analysis. Discussion: The Research Agenda for General Practice/Family Medicine highlights that the evidence on predictive values of prognostic indices in primary care is scarce. A prospective cohort like that of PROEPOC/COPD provides good opportunities for research into COPD and make communication easier between family practitioners, nursing staff, pneumologists and other professionals, supporting a multi-disciplinary approach to the treatment of these patients. Trial registration:ISRCTN52402811. Date: 15/01/2015. Prospectively registered
Azerbaijanâs Foreign Policy Strategies and the European Union: Successful resistance and pursued influence
In recent years, Azerbaijan has positioned itself on the international scene as an increasingly important and assertive actor. This essay focuses on Azerbaijanâs relations with the European Union (EU). It will identify the policy strategies used by Azerbaijan to engage with the EU in two areas where their interests and objectives do not align, namely democracy and human rights promotion policies, and agenda-setting of the Nagorno-Karabakh conflict. The essay highlights, first, the relevance of national independence, âbalancingâ and regime legitimacy in explaining Azerbaijanâs foreign policy strategies, and second, the mixed track record of Azerbaijanâs assertiveness, with different outcomes depending on whether the policy strategies are reactive or proactive
General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries
BACKGROUND: General practitioners (GPs) should regularly review patients' medications and, if necessary, deprescribe, as inappropriate polypharmacy may harm patients' health. However, deprescribing can be challenging for physicians. This study investigates GPs' deprescribing decisions in 31 countries. METHODS: In this case vignette study, GPs were invited to participate in an online survey containing three clinical cases of oldest-old multimorbid patients with potentially inappropriate polypharmacy. Patients differed in terms of dependency in activities of daily living (ADL) and were presented with and without history of cardiovascular disease (CVD). For each case, we asked GPs if they would deprescribe in their usual practice. We calculated proportions of GPs who reported they would deprescribe and performed a multilevel logistic regression to examine the association between history of CVD and level of dependency on GPs' deprescribing decisions. RESULTS: Of 3,175 invited GPs, 54% responded (Nâ=â1,706). The mean age was 50âyears and 60% of respondents were female. Despite differences across GP characteristics, such as age (with older GPs being more likely to take deprescribing decisions), and across countries, overall more than 80% of GPs reported they would deprescribe the dosage of at least one medication in oldest-old patients (>â80âyears) with polypharmacy irrespective of history of CVD. The odds of deprescribing was higher in patients with a higher level of dependency in ADL (OR =1.5, 95%CI 1.25 to 1.80) and absence of CVD (OR =3.04, 95%CI 2.58 to 3.57). INTERPRETATION: The majority of GPs in this study were willing to deprescribe one or more medications in oldest-old multimorbid patients with polypharmacy. Willingness was higher in patients with increased dependency in ADL and lower in patients with CVD
One consensual depression diagnosis tool to serve many countries: a challenge! A RAND/UCLA methodology
Objective
From a systematic literature review (SLR), it became clear that a consensually validated tool was needed by European General Practitioner (GP) researchers in order to allow multi-centred collaborative research, in daily practice, throughout Europe. Which diagnostic tool for depression, validated against psychiatric examination according to the DSM, would GPs select as the best for use in clinical research, taking into account the combination of effectiveness, reliability and ergonomics? A RAND/UCLA, which combines the qualities of the Delphi process and of the nominal group, was used. GP researchers from different European countries were selected. The SLR extracted tools were validated against the DSM. The Youden index was used as an effectiveness criterion and Cronbachâs alpha as a reliability criterion. Ergonomics data were extracted from the literature. Ergonomics were tested face-to-face.
Results
The SLR extracted 7 tools. Two instruments were considered sufficiently effective and reliable for use: the Hospital Anxiety and Depression Scale and the Hopkins Symptoms Checklist-25 (HSCL-25). After testing face-to-face, HSCL-25 was selected. A multicultural consensus on one diagnostic tool for depression was obtained for the HSCL-25. This tool will provide the opportunity to select homogeneous populations for European collaborative research in daily practice